SCHEMBL5545514

SCHEMBL5545514

CNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(Cc2ccccn2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.44
GRIN2B Q13224 2/20 0.44
ALDH1A1 P00352 5/20 0.43
LMNA P02545 3/20 0.43
TSHR P16473 3/20 0.43
KDM4E B2RXH2 3/20 0.43
PKM P14618 1/20 0.43
CNR2 P34972 6/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
HTT P42858 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
USP2 O75604 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
TP53 P04637 2/20 0.42
MAPT P10636 1/20 0.42
CNR1 P21554 1/20 0.41
FEN1 P39748 1/20 0.40
S1PR3 Q99500 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5545455 0.90 ALDH1A1 (0.46) GRIN1GRIN2BALDH1A1LMNATSHR
SCHEMBL5546547 0.90 ALDH1A1 (0.43) GRIN1GRIN2BALDH1A1LMNATSHR
SCHEMBL5538720 0.89 CNR2 (0.43) GRIN1GRIN2BALDH1A1LMNATSHR
SCHEMBL6061081 0.89 CNR2 (0.58) GRIN1GRIN2BALDH1A1LMNATSHR
SCHEMBL5547322 0.89 ALDH1A1 (0.43) GRIN1GRIN2BALDH1A1LMNATSHR
SCHEMBL5545372 0.86 CNR2 (0.45) ALDH1A1LMNATSHRKDM4EPKM
SCHEMBL5547227 0.86 GRIN1 (0.46) GRIN1GRIN2BALDH1A1LMNATSHR
SCHEMBL5546492 0.85 CNR2 (0.39) ALDH1A1TSHRCNR2L3MBTL1SMN1; SMN2
SCHEMBL5546970 0.85 CNR2 (0.48) GRIN1GRIN2BCNR2CNR1S1PR3
SCHEMBL5546974 0.85 CNR2 (0.48) GRIN1GRIN2BCNR2CNR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150225399-A1 HIV INTEGRASE INHIBITORS VIIV HEALTHCARE CO (US) 2015-08-13 US disclosed
US-20140256713-A1 2-OXONAPHTHYRIDINE-3-CARBOXAMIDES HIV INTEGRASE INHIBITORS SHIONOGI & CO., LTD. (JP) 2014-09-11 US disclosed
EP-1720856-B1 HIV INTEGRASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2013-08-14 EP disclosed
US-20070124152-A1 Hiv Integrase Inhibitors GLAXOSMITHKLINE LLC 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256713-A1 2-OXONAPHTHYRIDINE-3-CARBOXAMIDES HIV INTEGRASE INHIBITORS BCDIN3D, DUT, SAMHD1 GRIN1 1445/4885GRIN2B 1400/4885ALDH1A1 3812/4885
US-20150225399-A1 HIV INTEGRASE INHIBITORS ING2, API5, SAMHD1 GRIN1 3219/4885GRIN2B 4036/4885ALDH1A1 3073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.